{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:24:49Z","timestamp":1768458289688,"version":"3.49.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T00:00:00Z","timestamp":1368662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063153","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T21:11:19Z","timestamp":1368738679000},"page":"e63153","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["RANKL\/RANK\/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro"],"prefix":"10.1371","volume":"8","author":[{"given":"Sandra","family":"Casimiro","sequence":"first","affiliation":[]},{"given":"Khalid S.","family":"Mohammad","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Tato-Costa","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Alho","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Allan","family":"Lipton","sequence":"additional","affiliation":[]},{"given":"Theresa A.","family":"Guise","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Costa","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"RE Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"A Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"GR Mundy","year":"1997","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"KN Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"DM Anderson","year":"1997","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"H Hsu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"DL Lacey","year":"1998","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"44347","DOI":"10.1074\/jbc.M202009200","article-title":"A RANK\/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function","volume":"277","author":"AP Armstrong","year":"2002","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"20551","DOI":"10.1074\/jbc.273.32.20551","article-title":"Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase","volume":"273","author":"BG Darnay","year":"1998","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"WS Simonet","year":"1997","journal-title":"Cell"},{"key":"ref11","unstructured":"Dougall W (2009) Mechanistic Role of RANKL in Cancer induced Bone Diseases and Development of a Targeted Therapy to Inhibit this Pathway. In: Heymann D, editor. Bone Cancer - Progression and Therapeutic Approaches: Academic Press. pp. 385\u2013406."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"RJ Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"DH Jones","year":"2006","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pros.20678","article-title":"RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes","volume":"68","author":"AP Armstrong","year":"2008","journal-title":"Prostate"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bone.2006.11.006","article-title":"DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process","volume":"40","author":"K Mori","year":"2007","journal-title":"Bone"},{"key":"ref16","first-page":"S35, abstract #1095","article-title":"RANK ligand directly induces osteoclastogenic, angiogenic, chemoattractive and invasive factors on RANK-expressing human cancer cells MDA-MB-231 and PC3","volume":"19","author":"M Tometsko","year":"2004","journal-title":"J Bone Miner Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/path.2140","article-title":"Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B","volume":"211","author":"K Mori","year":"2007","journal-title":"J Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/ol.2011.487","article-title":"C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway","volume":"3","author":"L Zhang","year":"2012","journal-title":"Oncol Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"E Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"D Schramek","year":"2010","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1158\/0008-5472.CAN-12-0044","article-title":"RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis","volume":"72","author":"M Palafox","year":"2012","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e19234","DOI":"10.1371\/journal.pone.0019234","article-title":"Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients","volume":"6","author":"D Santini","year":"2011","journal-title":"Plos One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jcp.22402","article-title":"Expression pattern of receptor activator of NFkappaB (RANK) in a series of primary solid tumors and related bone metastases","volume":"226","author":"D Santini","year":"2011","journal-title":"J Cell Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1078-0432.162.11.1","article-title":"Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma","volume":"11","author":"P Bhatia","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cncr.21978","article-title":"Expression of RANKL\/RANK\/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation","volume":"107","author":"G Chen","year":"2006","journal-title":"Cancer"},{"key":"ref26","article-title":"Expression pattern of receptor activator of NFkappaB (RANK) in a series of primary solid tumors and related bone metastases","author":"D Santini","year":"2010","journal-title":"J Cell Physiol"},{"key":"ref27","first-page":"199","article-title":"Expression profile of receptor activator of nuclear-kappaB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer","volume":"33","author":"S Owen","year":"2013","journal-title":"Anticancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10585-007-9113-7","article-title":"Breast cancer progression: insights into multifaceted matrix metalloproteinases","volume":"24","author":"V Chabottaux","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"ref29","first-page":"85","article-title":"Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases","volume":"1785","author":"TJ Wilson","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Y Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","article-title":"ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis","volume":"23","author":"X Lu","year":"2009","journal-title":"Genes Dev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.bone.2010.10.068","article-title":"Expression of matrix metalloproteinase 1 (MMP1) and dickkopf-1 (DKK1) in bone metastatic tissue (BMT) and in serum of patients with bone metastases (BM) from different solid tumors","volume":"48","author":"LA Costa","year":"2011","journal-title":"Bone"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1359\/jbmr.2001.16.11.2027","article-title":"Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions","volume":"16","author":"O Peyruchaud","year":"2001","journal-title":"J Bone Miner Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10585-011-9438-0","article-title":"Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors","volume":"29","author":"S Casimiro","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2407-9-188","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature","volume":"9","author":"A Kohrmann","year":"2009","journal-title":"BMC Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.canlet.2008.11.017","article-title":"Identification of brain- and bone-specific breast cancer metastasis genes","volume":"276","author":"A Klein","year":"2009","journal-title":"Cancer Lett"},{"key":"ref37","first-page":"139","article-title":"Biomarker profile in breast carcinomas presenting with bone metastasis","volume":"3","author":"OL Bohn","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-008-0085-3","article-title":"Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model","volume":"116","author":"SM Eck","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.20.3.850","article-title":"Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status","volume":"20","author":"L Costa","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2004.06.019","article-title":"A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells","volume":"35","author":"TL Andersen","year":"2004","journal-title":"Bone"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"abstr 1024","DOI":"10.1200\/jco.2008.26.15_suppl.1024","article-title":"Markers of bone turnover (ICTP, NTX) and serum matrix metalloproteinase 1 (MMP1) as prognostic markers in breast cancer patients (BC) with bone metastases (BM) treated with bisphosphonates (BP)","volume":"26","author":"LA Costa","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-06-2490","article-title":"Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer","volume":"67","author":"JT Buijs","year":"2007","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"TA Guise","year":"1996","journal-title":"J Clin Invest"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T20:07:51Z","timestamp":1688242071000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063153"}},"subtitle":[],"editor":[{"given":"Chih-Hsin","family":"Tang","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,5,16]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063153","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,16]]}}}